National Wellbeing Survey links rising chronic conditions to fourfold increase in prescription drug misuse among working-age adults

Researchers Oshaji and London analyzed five waves of the National Wellbeing Survey covering 18-64 year olds who self-reported ten conditions including hypertension, diabetes, COPD, PTSD, and depression. Misuse encompassed any non-prescribed use or deviation from intended dosing for opioids, tranquilizers, sedatives, or stimulants in the prior year. The clear gradient persisted after basic demographic adjustment, with mental health conditions driving higher rates than purely physical comorbidities.

Prior studies such as the 2019 NSDUH analyses and 2022 JAMA Internal Medicine cohort on chronic pain and opioid escalation captured narrower slices; this survey uniquely pairs full disease burden with multi-class misuse. Underreported gaps include limited access to non-pharmacologic therapies and fragmented prescribing across specialists, patterns that amplify self-medication when patients juggle multiple diagnoses without coordinated care.

Next steps require longitudinal linkage of NWS respondents to claims data to test whether integrated behavioral health models reduce incidence below 5% in multi-morbid groups within two years. Regulatory tracking of stimulant and sedative prescribing volumes by comorbidity count would clarify supply-side contributions.

The observational design establishes association but cannot isolate causation or rule out reverse pathways such as untreated symptoms prompting misuse; randomized trials of multidisciplinary care are needed to confirm preventive impact.